ICTRP Search Portal

Main

Note: This record shows only 22 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register.

Register:	ClinicalTrials.gov
Last refreshed on:	15 August 2022
Main ID:	NCT03315130
Date of registration:	16/10/2017
Prospective Registration:	No
Primary sponsor:	Ra Pharmaceuticals
Public title:	Safety and Efficacy Study of RA101495 in Subjects With Generalized Myasthenia Gravis
Scientific title:	A Phase 2, Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Safety, Tolerability, and Preliminary Efficacy of RA101495 in Subjects With Generalized Myasthenia Gravis
Date of first enrolment:	October 11, 2017
Target sample size:	45
Recruitment status:	Completed
URL:	https://clinicaltrials.gov/show/NCT03315130
Study type:	Interventional
Study design:	Allocation: Randomized. Intervention model: Parallel Assignment. Primary purpose: Treatment. Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor).
Phase:	Phase 2

Countries of recruitment
Canada	United States

Contacts

Name:	UCB Cares
Address:
Telephone:
Email:
Affiliation:	001 844 599 2273 (UCB)

Key inclusion & exclusion criteria

Health Condition(s) or Problem(s) studied

Intervention(s)

Primary Outcome(s)

Secondary Outcome(s)

Secondary ID(s)

Source(s) of Monetary Support

Secondary Sponsor(s)

Ethics review

Results

Results available:	Yes
Date Posted:	27/06/2022
Date Completed:
URL:	https://clinicaltrials.gov/ct2/show/results/NCT03315130

Disclaimer: Trials posted on this search portal are not endorsed by WHO, but are provided as a service to our users. In no event shall the World Health Organization be liable for any damages arising from the use of the information linked to in this section. None of the information obtained through use of the search portal should in any way be used in clinical care without consulting a physician or licensed health professional. WHO is not responsible for the accuracy, completeness and/or use made of the content displayed for any trial record.